{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:52:56Z","timestamp":1789077176442,"version":"build-2803163510"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Kowa Pharmaceuticals America, Inc"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Statins are first\u2010line for cholesterol lowering and prevention of atherosclerotic cardiovascular disease (ASCVD), but their use is complicated by side effects and potential for drug\u2013drug interactions. Provider\u2010patient communication is the basis of the recommended shared decision\u2010making, but relatively little is known about this in the context of statin use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We surveyed 5014 US adults prescribed a statin for hypercholesterolemia to learn their perspectives on communication with their provider.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety\u2010four percent reported currently taking a statin while 6% had stopped. Past users vs current users were more likely to be female, age &lt; 65 years, and to have fewer cardiovascular disease\u2013related comorbidities (hypertension, type 2 diabetes mellitus, and coronary heart disease, respectively). Although 93% of current statin users were taking \u22651 other prescription medications (median of 4), 76% were \u201cnot at all\u201d\/\u201cnot very concerned\u201d about potential drug\u2013drug interactions with their statin, and fewer than one\u2010quarter recalled mention of these from their provider. Ninety\u2010five percent of subjects said it was \u201cextremely\u201d\/\u201csomewhat\u201d important that their healthcare provider take \u201can individualized approach to selecting the right statin,\u201d but 73% and 76%, respectively, said their statin choice was made with little or no input from them. Only 25% were told that \u201csome statins might be more likely than others to interact with other medications,\u201d and only 18% (and only 20% of past users) were told that \u201ctheir particular statin might interact with other medications.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Provider\u2010patient communication regarding statin therapy appears inadequate, by patient recall, and efforts to improve it are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1002\/clc.22975","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T06:54:15Z","timestamp":1526021655000},"page":"710-720","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy"],"prefix":"10.1002","volume":"41","author":[{"given":"Eliot A.","family":"Brinton","sequence":"first","affiliation":[{"name":"Utah Lipid Center  Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"US Centers for Disease Control and Prevention. Heart disease statistics and maps.https:\/\/www.cdc.gov\/heartdisease\/facts.htm. Updated: November 28 2017. Accessed March 15 2018."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P150"},{"key":"e_1_2_6_4_1","first-page":"116","article-title":"Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register\u2010based nationwide study","volume":"16","author":"Helin\u2010Salmivaara A","year":"2010","journal-title":"Am J Manag Care."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181ee707e"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.8.1035"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.122602"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.03.003"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.03.001"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.02.016"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.10.006"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.05.003"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.09.006"},{"key":"e_1_2_6_15_1","unstructured":"StoneNJ RobinsonJ LichtensteinAH et al. 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation.2013;01.cir.0000437738.63853.7a."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.03.003"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP171764.APPGL"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.22975","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T14:15:20Z","timestamp":1735222520000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.22975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/clc.22975"],"URL":"https:\/\/doi.org\/10.1002\/clc.22975","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"2018-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}